Collegium to Report First Quarter 2023 Financial Results on May 4, 2023
April 20 2023 - 8:00AM
Collegium Pharmaceutical, Inc. (Nasdaq: COLL), a leading,
diversified specialty pharmaceutical company committed to improving
the lives of people living with serious medical conditions, today
announced that it will report first quarter 2023 financial results
after the market closes on Thursday, May 4, 2023. Following
the release of the financials, the Company will host a live
conference call and webcast at 4:30 p.m. ET.
Conference Call
Information To access the conference call, please
dial (877) 407-8037 (U.S.) or (201) 689-8037 (International) and
reference the “Collegium Pharmaceutical Q1 2023 Earnings Call.” An
audio webcast will be accessible from the Investors section of the
Company’s website: www.collegiumpharma.com. The webcast will
be available for replay on the Company’s website approximately two
hours after the event.
About Collegium Pharmaceutical,
Inc.Collegium is a leading, diversified specialty
pharmaceutical company committed to improving the lives of people
living with serious medical conditions. Collegium’s headquarters
are located in Stoughton, Massachusetts. For more information,
please visit the Company’s website at www.collegiumpharma.com.
Investor Contact: Christopher
James, M.D.
Vice President, Investor Relationsir@collegiumpharma.com
Media Contact:Marissa SamuelsVice
President, Corporate
Communicationscommunications@collegiumpharma.com
Collegium Pharmaceutical (NASDAQ:COLL)
Historical Stock Chart
From Jun 2024 to Jul 2024
Collegium Pharmaceutical (NASDAQ:COLL)
Historical Stock Chart
From Jul 2023 to Jul 2024